Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue Doppler imaging and plasma N-terminal probrain natriuretic peptide for the identification of hypertrophic cardiomyopathy mutation carriers.

The American journal of cardiology - 1 Oct 2013

Silva Doroteia, Madeira Hugo, Almeida Augusto, Brito Dulce

Abstract excerpt

Previous studies have shown that tissue Doppler imaging (TDI) is able to identify mutation carriers of hypertrophic cardiomyopathy (HC) before the development of the clinical phenotype. However, data are scarce and have sometimes been controversial. We performed a systematic study that included conventional echocardiography, TDI, and plasma NT-probrain natriuretic peptide (NT-proBNP) measurement to evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Echocardiography, Doppler

Share to Heterozygote

Share to Myosins

Share to Natriuretic Peptide, Brain

Share to Peptide Fragments

Share to Troponin

Source

Identifiers

PMID: 23831167
DOI: 10.1016/j.amjcard.2013.05.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue Doppler imaging and plasma N-terminal probrain natriuretic peptide for the identification of hypertrophic cardiomyopathy mutation carriers.PMID 23831167Read ↗

Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging.Semantic proximity Read ↗

Diastolic Dysfunction of Hypertrophic Cardiomyopathy Genotype-Positive Subjects Without Hypertrophy Is Detected by Tissue Doppler Imaging: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy.Semantic proximity Read ↗

Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy.Semantic proximity Read ↗

Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.Semantic proximity Read ↗

Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.Semantic proximity Read ↗

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.Semantic proximity Read ↗

Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis.Semantic proximity Read ↗

Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Early detection of Fabry cardiomyopathy by tissue Doppler imaging.Semantic proximity Read ↗

Early Diagnosis of Abnormal Left Ventricular Systolic Functions of Rare Pathogenic Titin Mutation Gene Carriers in FHCM by Three-Dimensional Speckle Tracking Echocardiography Combined with Gene Detection.Semantic proximity Read ↗

Screening for pre-clinical hypertrophic cardiomyopathy by tissue Doppler imaging.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.